SCHEMBL6410802

SCHEMBL6410802

COCCNC(=O)C1c2ccc(OC)cc2C(=O)N(C)C1c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
ALDH1A1 P00352 6/20 0.47
HTT P42858 3/20 0.47
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
GLA P06280 1/20 0.45
CASP1 P29466 1/20 0.45
KMT2A Q03164 2/20 0.44
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
MDM2 Q00987 1/20 0.42
TSHR P16473 2/20 0.41
CYP3A4 P08684 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2C9 P11712 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6418414 0.90 ALDH1A1 (0.47) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6413224 0.88 ALDH1A1 (0.60) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6418752 0.84 NPSR1 (0.55) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6411886 0.83 KMT2A (0.55) GAAALDH1A1KDM4EKMT2AMAPK1
SCHEMBL6416797 0.83 GAA (0.44) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6410831 0.83 ALDH1A1 (0.58) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6411589 0.80 MDM2 (0.68) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6418369 0.79 GLA (0.51) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6414939 0.79 ALDH1A1 (0.74) GAAALDH1A1HTTKDM4EMAPT
SCHEMBL6412385 0.79 ALDH1A1 (0.74) GAAALDH1A1HTTKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD GAA 2485/4885ALDH1A1 1368/4885HTT 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.